Cargando…
Intramembrane proteolysis of an extracellular serine protease, epithin/PRSS14, enables its intracellular nuclear function
BACKGROUND: Epithin/PRSS14, a type II transmembrane serine protease, is an emerging target of cancer therapy because of its critical roles in tumor progression and metastasis. In many circumstances, the protease, through its ectodomain shedding, exists as a soluble form and performs its proteolytic...
Autores principales: | Cho, Youngkyung, Kim, Sang Bum, Kim, Jiyoon, Pham, An Vuong Quynh, Yoon, Min Ji, Park, Jeong Hwan, Hwang, Ki-Tae, Park, Dongeun, Cho, Yongcheol, Kim, Moon Gyo, Kim, Chungho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7271384/ https://www.ncbi.nlm.nih.gov/pubmed/32493324 http://dx.doi.org/10.1186/s12915-020-00787-3 |
Ejemplares similares
-
A JUN N-terminal kinase inhibitor induces ectodomain shedding of the cancer-associated membrane protease Prss14/epithin via protein kinase CβII
por: Yoon, Joobyoung, et al.
Publicado: (2020) -
Environment-Sensitive Ectodomain Shedding of Epithin/PRSS14 Increases Metastatic Potential of Breast Cancer Cells by Producing CCL2
por: Jang, Jiyoung, et al.
Publicado: (2022) -
Targeting metastatic breast cancer with peptide epitopes derived from autocatalytic loop of Prss14/ST14 membrane serine protease and with monoclonal antibodies
por: Kim, Ki Yeon, et al.
Publicado: (2019) -
Impact of suppression of tumorigenicity 14 (ST14)/serine protease 14 (Prss14) expression analysis on the prognosis and management of estrogen receptor negative breast cancer
por: Kim, Sauryang, et al.
Publicado: (2016) -
The testis-specific serine proteases PRSS44, PRSS46, and PRSS54 are dispensable for male mouse fertility(†)
por: Holcomb, Richard J, et al.
Publicado: (2020)